Dr. Huo ISC25 LB38 patient quality of life

Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt)

News release

Please see AHA/ASA Multimedia Materials Usage Policy.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

Download (109.6 MB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED